Patient had cataract surgery on (b)(6) 2016.Significant, greater than expected eye inflammation diagnosed on (b)(6) 2016.On (b)(6) 2016 leiter's compounding pharmacy recalled medication used on patient lidocaine 1 percent, 1.5 percent phenylephrine preservative free.The recall indicated that the baxter filter recall was the reason for this medication recall.This was one of 5 cataract patients who had tass or inflammation diagnosed who had received the recalled products prepared by the compounding pharmacy.Diagnosis or reason for use: standing order for cataract surgery followed by viscoat.Is the product compounded: yes.Event abated after use stopped or dose reduced: yes.Event reappeared after reintroduction: doesn't apply.All day of surgery (b)(6) 2016.
|